[HTML][HTML] Thiadiazole derivatives as anticancer agents

M Szeliga - Pharmacological Reports, 2020 - Springer
In spite of substantial progress made toward understanding cancer pathogenesis, this
disease remains one of the leading causes of mortality. Thus, there is an urgent need to …

Advances in the discovery of anthraquinone-based anticancer agents

AS Tikhomirov, AA Shtil… - Recent patents on anti …, 2018 - ingentaconnect.com
Background: The anthracene-9, 10-dione (anthraquinone) derivatives represent an
exceptionally valuable class in anticancer drug development. An outstanding antitumor …

DNA binders in clinical trials and chemotherapy

A Ali, S Bhattacharya - Bioorganic & medicinal chemistry, 2014 - Elsevier
Cancer has always been a dreadful disease and continues to attract extensive research
investigations. Various targets have been identified to restrain cancer. Among these DNA …

Telomerase: a prominent oncological target for development of chemotherapeutic agents

K Vishwakarma, R Dey, H Bhatt - European Journal of Medicinal Chemistry, 2023 - Elsevier
Telomerase is a ribonucleoprotein (RNP) responsible for the maintenance of chromosomal
integrity by stabilizing telomere length. Telomerase is a widely expressed hallmark …

Temporal expression patterns of distinct cytokines and M1/M2 macrophage polarization regulate rheumatoid arthritis progression

CC Kung, SP Dai, H Chiang, HS Huang… - Molecular biology …, 2020 - Springer
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation
of synovial joints and often associated with chronic pain. Chronic joint inflammation is …

[HTML][HTML] Natural Products–Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry

GQ Chen, HY Guo, ZS Quan, QK Shen, X Li, T Luan - Molecules, 2023 - mdpi.com
Pyrazine is a six-membered heterocyclic ring containing nitrogen, and many of its
derivatives are biologically active compounds. References have been downloaded through …

[HTML][HTML] Transcriptomic-based identification of the immuno-oncogenic signature of cholangiocarcinoma for HLC-018 multi-target therapy exploration

B Lawal, YC Kuo, SL Tang, FC Liu, ATH Wu, HY Lin… - Cells, 2021 - mdpi.com
Cholangiocarcinomas (CHOLs), hepatobiliary malignancies, are characterized by high
genetic heterogeneity, a rich tumor microenvironment, therapeutic resistance, difficulty …

In vivo pharmacokinetic and anticancer studies of HH-N25, a selective inhibitor of topoisomerase I, and hormonal signaling for treating breast cancer

B Lawal, YC Kuo, MR Sumitra, ATH Wu… - Journal of …, 2021 - Taylor & Francis
Purpose Breast cancer is the most frequently diagnosed cancer globally, and the leading
cause of cancer-associated mortality among women. The efficacy of most clinical …

G-quadruplex binding ligands: from naturally occurring to rationally designed molecules

T Vy Thi Le, S Han, J Chae… - Current pharmaceutical …, 2012 - ingentaconnect.com
Guanine-rich nucleic acid sequences are known to form G-quadruplex-four-stranded DNA or
RNA structures stabilized by an array of Hoogsteen hydrogen bonds. G-quadruplex …

Recent developments in the synthesis and applications of 1, 2, 5-thia-and selenadiazoles. A review

LS Konstantinova, EA Knyazeva… - Organic Preparations and …, 2014 - Taylor & Francis
1, 2, 5-Chalcogenadiazoles (oxa-, thia-, selena-, and telluradiazoles) have been known for
many years. Their first representative, 2, 1, 3-benzothiadiazole (1), was discovered in 1889 …